Andy,
The list was very helpful. There are, however, still some blanks and
that again relates to top customers, products and suppliers. I hope
the formatting has come out so it is easily read.
Advanced Medical Solutions Group plc
1.a.
"AMS provides a full range of advanced woundcare products which are
supplied globally through major woundcare partners, private label
distributors and in the UK direct to the NHS under the ActivHeal®
brand.
Through its MedLogic division, AMS is also a leader in the use of
tissue adhesives for closing wounds in the Accident & Emergency and
Operating Room areas.?
http://www.admedsol.com/
Founded in 1991 ?the majority of AMS' products are marketed and
distributed through blue-chip partners; Professional Woundcare
products into hospitals and nursing homes, and Consumer Healthcare
products into retail pharmacies and mass retailers.?
Two trading subsidiaries:
?AMS Ltd based in Winsford, Cheshire focused on advanced woundcare
dressings and MedLogic Global Ltd, based in Plymouth, Devon focused on
medical adhesives and sealants.?
?The Group has an active R&D programme which provides an Innovation
Pipeline of new products to existing markets and exploits core AMS
Technology in medical device areas other than woundcare.?
http://www.admedsol.com/corporate/index.html
1.b.
Additional information
http://www.londonstockexchange.com/en-gb/products/companyservices/ourmarkets/mainmarket/landMARK/northwest/casestudies/advancedmedicalsolutionsplc.htm
2.
175
http://goliath.ecnext.com/coms2/product-compint-0000770736-page.html
165
http://www.londonstockexchange.com/en-gb/products/companyservices/ourmarkets/mainmarket/landMARK/northwest/casestudies/advancedmedicalsolutionsplc.htm
3.
The Company?s major shareholders at 28 February 2004 are in the Annual
report 2003 page 17
http://www.admedsol.com/corporate/pdf%20files/annual_report_2003_indexed.pdf
Unable to find current shareholders, but these regulatory disclosures
detail the changes since then:
Cavendish Asset Management Limited 8,450,000 5.95% Discretionary
clients of Cavendish hold 4,750,000 Ordinary Shares, whilst the
remaining 3,700,000 Ordinary Shares are held by Cavendish
Opportunities fund.
http://fool.uk-wire.com/cgi-bin/articles/200503151636247904J.html
Close Brothers 12,372,938 8.71%
http://fool.uk-wire.com/cgi-bin/articles/200501311721590252I.html
Newton Investment Management Limited 19,800,020 13.94%
http://fool.uk-wire.com/cgi-bin/articles/200409301627405555D.html
BNY Trust Company Limited, as trustee of the MLIT - UK Smaller
Companies Fund, 3,527,742 2.48%
http://fool.uk-wire.com/cgi-bin/articles/200409161646450519D.html
4.
Geoffrey Vernon 675,164 shares
Donald Evans 517,680 shares
http://fool.digitallook.com/?action=dealings&ticker=AMS
5.
Limited information. Brokers and analyst reports are only available on
premium pay sites.
http://uk.finance.yahoo.com/q/ae?s=AMS.L
6.a.
Board of Directors
Geoffrey .N. Vernon Non-Executive Chairman
Don.W Evans Chief Executive Officer
Mary.G. Tavener Finance Director & Company Secretary
Ralph Stephen Harris Non-Executive Director
See Page 14 of 2003 Annual Report pdf for antecedents
http://www.admedsol.com/corporate/pdf%20files/annual_report_2003_indexed.pdf
Evans prior to 2000 ?previously in charge of the Professional
Woundcare and Consumer Skincare operations?
http://www.admedsol.com/corporate/reports/prelims99/chairmansstatement.html
6.b.
Times Article:
?When success comes in threes: STAGES OF DEVELOPMENT: AMS needed three
chiefs and radical change to progress, findsNicki Brimicombe.?
Evans former ?senior Johnson & Johnson executive?. Tavener joined the
company from the speciality chemicals group BTP. Access Times Archive
to view article.
Times 23.08.2001
Detailed additional information on Vernon.
http://www.tvmvc.com/site/team/vernon.php
?The appointment of Dr. Geoffrey Vernon to Hepavec´s Board of [?]
expected to be a great asset to HepaVec. Dr. Vernon currently serves
as Chairman of Ziggus Holdings Limited, a provider of independent
Chairman and non-executive Director services to life sciences
companies. Previous to these positions, Dr. Vernon was a partner in
the life sciences division of Advent, a privately owned venture
capitalist group specializing in investing in technology focused
companies and Executive Director of the merchant bank, Rothschild
Asset Management Ltd.?
http://www.bionews.net/b/5/I41CD43E-001.htm!ArcEntryInfo=0004.15.I41CD43E
7.
See Page 14 of Annual report pdf. No other background information
found. No interviews. Most soundbites appear in press releases by the
company. These two search terms below will link to some of them. The
remainder can be accessed through their Press archive
http://www.admedsol.com/corporate/press/index.html
?Chief executive Don Evans said?
://www.google.co.uk/search?hl=en&q=%22Chief+executive+Don+Evans+said%22&btnG=Search&meta=
"Chief Executive of Advanced Medical Solutions Group plc, said"
://www.google.co.uk/search?hl=en&q=%22Chief+Executive+of+Advanced+Medical+Solutions+Group+plc%2C+said%22&btnG=Search&meta=
CEO Don Evans is a member of the London Stock Exchange's North West
Regional Advisory Group.
http://www.londonstockexchange.com/en-gb/products/companyservices/ourmarkets/mainmarket/landMARK/northwest/casestudies/advancedmedicalsolutionsplc.htm
8.
Limited information found.
Senior Management
Tom A. Donovan Managing Director, AMS Ltd
Richard Stenton Managing Director, MedLogic Global Ltd
Geoffrey C. Axten General Manager - Consumer Division
http://www.admedsol.com/corporate/index.html
?Tom [Donovan] has a wide range of experience gained internationally
in sales, marketing and operations in the medical and related
industries. He was the former founder and Managing Director of Yew
Tree Pharmaceuticals. Tom will work alongside Richard Stenton,
Managing Director of the recently acquired MedLogic medical adhesives
and sealants business, to maximise growth of the Group's Professional
product range targeted at hospitals and nursing homes.?
?Godfrey Axten, aged 54, has been appointed to run a focused Consumer
Division addressing the retail pharmacy, sports and grocery market for
first aid, footcare and skincare, utilising technology transferred
from both the Advanced Woundcare and MedLogic operations. Godfrey has
had a successful career in sales, marketing, business development and
senior general management in Consumer OTC with Schering Plough and
Warner Lambert in the USA and more recently with Novartis Consumer
Health, with positions in Scandinavia, Japan and as UK Managing
Director. Godfrey brings the appropriate expertise to establish and
deliver a viable global Consumer business for AMS products.?
http://bestinvest.uk-wire.com/cgi-bin/articles/200301160700202428G.html
9.
See comments in preliminary report for year end 2004
http://www.admedsol.com/corporate/reports/prelims04/index.html
Latest press releases
http://www.admedsol.com/corporate/press/index.html
"Advanced Medical Solutions Group plc Announce major new partnership
and trading update AMS to Private Label Wound Care Products for
Cardinal Health for U.S. Distribution"
http://fool.uk-wire.com/cgi-bin/articles/200407130700187636A.html
10.
Not specifically identified.
"In addition to AMS' range of branded dressings for its partners, the
company is able to supply a range of standard products packaged and
cartoned under the AMS ActivHeal? brand name.
Protection of skin against breakdown by moisture, shear and friction
is an important area of advanced woundcare, LiquiShield® is a product
that addresses this area."
http://www.admedsol.com/professional/awound.html
Liquiband products
http://www.admedsol.com/professional/closure.html
MedLogic Product brochure with additional background information
http://www.admedsol.com/corporate/pdf%20files/medlogicbrochure.pdf
Consumer products
http://www.admedsol.com/consumer/index.html
11.
Not identified
"Advanced Medical Solutions received a boost for its wound care
products yesterday, after they were listed in the Department of
Health's Drug Tariff, the catalogue of approved products for the
National Health Service."
http://www.bnn-online.co.uk/news_datesearch.asp?page=5&SearchDate=19/Dec/2003&Year=2003
12.
Not identified, but see distributors below.
13.
Queen Mary University of London report of visit in 2000
http://www.materials.qmul.ac.uk/indvisit/2000/ams.php
2001 "Advanced Medical Solutions Group plc has been awarded grants
totalling £130,000, in support of the company?s research on tissue
engineering."
http://www.f5nanomed.org/PRESS%20RELEASEBAMS.html
Times 17.03.05
"DON EVANS, chief executive of Advanced Medical Solutions, is a
believer in his company?s products. He had a facial operation the
other day and insisted the hospital did not stitch the wound but
instead used LiquiBand Surgical, which glues the affected bits
together. Yesterday he met the City analysts for the company?s
results. ?His face is firmly attached,? reports one observer."
http://www.timesonline.co.uk/article/0,,630-1528349,00.html
14.
Contact details and names. No other details found.
http://www.admedsol.com/about/contact.html
15.
Press release for preliminary results Ended 31 December 2004
http://www.admedsol.com/corporate/reports/prelims04/index.html
Interim Report and results 30/6/04
http://www.admedsol.com/corporate/pdf%20files/interim_report_2004.pdf
Annual Report 2003
http://www.admedsol.com/corporate/pdf%20files/annual_report_2003_indexed.pdf
16. a.& b.
Press release
?collaboration with strategic partner for marketing of wound closure
products in the US market? (no name supplied)
http://www.admedsol.com/corporate/press/2005/050405liquiband.html
07.01.2002
"Monday's edition of The Financial Times held an article on Advanced
Medical Solutions Group (AMS.L) (11.25p), who have announced a
licensing deal with Noble Fiber Technologies of the US, to incorporate
Noble's 'X-STATICÒ' anti-bacterial silver fibres into their
seaweed-derived moist wound healing dressings. The deal was announced
this morning (see below) and by 10:02 the shares were up 0.75p,
marking a rise of 7.1%."
http://www.cityequities.com/penny_share_review.asp?issue=115
?The majority of AMS business is through marketing and distribution
partners with major international woundcare companies such as 3M,
Smith & Nephew, Johnson & Johnson and Molnlycke under their leading
brands or by supplying a range of private label products to major
regional distributors, such as Cardinal Health.?
http://www.admedsol.com/professional/awound.html
answerfinder-ga |
,
0 Comments
)